Figure 6

PES synergizes with bortezomib in the induction of PEL cell death. BC3 and BCBL1 were treated with bortezomib (10 nM), PES (10 μM) or combination of both for 16 h and viability was assessed by trypan-blue exclusion. Mean±S.D. and P-value are also reported P-value=0.01, P-value=0.05